Cirino Botta - Concepedia

Author

Cirino Botta

Also Known As

Botta C, Botta, Cirino, C Botta, C. Botta, C.B. Botta, Cirino Botta, Ciro Botta, Enrica Martino, Hematology Unit AO of Cosenza, Cosenza, Italy

288

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Magna Graecia University University of Siena Temple University Ospedale Annunziata di Cosenza Clinica Universidad de Navarra

About

Cirino Botta is an author at Magna Graecia University specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	844
2	Health Sciences	4	4	161
3	Public Health	2	2	43
4	Biostatistics	2	2	63
5	Engineering	1	1	44

Cirino Botta

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease Marco Rossi, Maria Rita Pitari, Nicola Amodio, Journal of Cellular Physiology	2012	184
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma Cristina Pérez, Cirino Botta, Aintzane Zabaleta, Blood	2020	151
Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation Annamaria Gullà, Eugenio Morelli, Mehmet Samur, Blood Cancer Discovery	2021	128
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo Eugenio Morelli, Emanuela Leone, Maria Eugenia Gallo Cantafio, Leukemia	2015	122
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells Annamaria Gullà, Maria Teresa Di Martino, Maria Eugenia Gallo Cantafio, Clinical Cancer Research	2015	118
A p53‐Dependent Tumor Suppressor Network Is Induced by Selective miR‐125a‐5p Inhibition in Multiple Myeloma Cells Marzia Leotta, Lavinia Biamonte, Lavinia Raimondi, Journal of Cellular Physiology	2014	102
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts Maria Rita Pitari, Marco Rossi, Nicola Amodio, Oncotarget	2015	96
Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma Pierpaolo Correale, Maria Rotundo, Cirino Botta, Clinical Cancer Research	2011	93
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients Cirino Botta, Vito Barbieri, Domenico Ciliberto, Cancer Biology & Therapy Inflammatory Lung DiseaseBaseline PredictsLung InflammationImmunologyInflammatory Index	2013	92
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients EC Martino, Gabriella Misso, Pierpaolo Pastina, Cell Death Discovery	2016	89

Page 1